Eikon Therapeutics targets $908.2 million valuation in U.S. IPO

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/4/2026

1. ZS
2. LULU
3. IOT
4. SPY
5. PATH
6. DOCU
7. ASAN
8. NVDA
9. CIEN
10. GWRE

Go back to Eikon Therapeutics targets $908.2 million valuation in U.S. IPO
(NASDAQ: EIKN) Delayed: 10.86 -0.1 (0.91%)
Previous Close $10.96    52 Week High $ 
Open $10.81    52 Week Low $ 
Day High $11.05    P/E N/A 
Day Low $10.62    EPS $ 
Volume 238,685